IPSC
Century Therapeutics Inc
1.50$
-3.3%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +81.1% | +219.0% | -9.8% | +2.6% | +427.6% | +2,516.0% | -100.0% | – | – | – | – | – | |
| – | -2.2% | -85.5% | +7.3% | -4.8% | +0.6% | – | – | -16.1% | -84.2% | -15.4% | – | – | |
| – | – | – | -9.8% | +2.6% | +427.6% | +2,516.0% | -124.6% | – | – | – | – | – | |
| – | -13.0% | +0.5% | +16.2% | +0.0% | +7.9% | -9.5% | +1.0% | -16.1% | -12.6% | -28.4% | +39.0% | – | |
| – | -4.4% | +1.8% | -5.0% | +0.6% | -7.1% | +8.4% | -7.2% | -12.4% | -86.0% | +588.2% | -12.0% | – | |
| – | +67.4% | +48.0% | +10.5% | +0.2% | +16.5% | -15.6% | -77.7% | +74.2% | +51.9% | +8.9% | +62.4% | – | |
| – | – | – | – | – | – | – | -146.7% | – | – | – | – | – | |
| – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -142.5% | – | – | – | – | – | |
| – | -246.8% | – | +2,100.0% | -136.4% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -142.5% | – | – | – | – | – | |
| – | – | – | – | – | – | – | -136.8% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.